Senator Susan Collins, joined by fellow Republican senators, has publicly voiced strong opposition to President Trump’s proposed cuts to biomedical research funding. During a Senate appropriations committee hearing, Collins emphasized the need to reverse these cuts, describing them as harmful and warning that they threaten the United States’ leadership in medical research. The president of MDI Biological Lab also testified, highlighting the potential long-lasting impacts of the cuts on research initiatives. Collins and her colleagues are calling for urgent action to safeguard funding for vital scientific research.